STERIS plc (STE)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $25.43B
Last updated: Nov 17, 2026 at 4:20 PM ET
STERIS plc (STE) Statistics
STERIS (STE) has a market cap of $25.43B and an enterprise value of $26.91B. Its trailing P/E is 23.6x.
Total Valuation
Enterprise value is 5.82% above the market cap, as debt exceeds cash.
| Market Cap | $25.43B |
|---|---|
| Enterprise Value | $26.91B |
| Latest price (Nov 17, 2026) | $257.35 |
Key Dates
The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 17, 2026.
| Next Earnings Date | Feb 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Last Ex-Dividend Date | Nov 17, 2026 |
| Next Payment Date | Dec 17, 2026 |
| Fiscal Year End | March |
Valuation Ratios
Sales and book value multiples are 4.1x and 3.4x. Its year-end P/E ranged from 18.9x to 32.5x from 2016 to 2025.
| P/E Ratio | 23.6x |
|---|---|
| Forward P/E | 22.4x |
| P/S Ratio | 4.1x |
| Forward P/S | 4.0x |
| P/B Ratio | 3.4x |
| P/TBV Ratio | 15.8x |
| P/FCF Ratio | 26.7x |
| P/OCF Ratio | 19.7x |
| PEG Ratio | 2.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.8x EBITDA and 28.2x free cash flow.
| EV / Earnings | 32.4x |
|---|---|
| EV / Sales | 4.4x |
| EV / EBITDA | 15.8x |
| EV / EBIT | 22.8x |
| EV / FCF | 28.2x |
Price Statistics
The stock is up 0.09% over 52 weeks and trades 14.48% above its 50-day average.
| Beta (1Y) | 0.40 |
|---|---|
| 52-Week Change | +0.09% |
| 1-Month Change | +15.94% |
| 3-Month Change | +8.96% |
| 6-Month Change | +20.75% |
| 5-Year Change | -2.83% |
| 10-Year Change | +239.90% |
| Total Return (1Y) | +1.36% |
| Total Return (3Y CAGR) | +9.53% |
| Total Return (5Y CAGR) | +2.74% |
| Return vs SPY (1Y) | -11.17% |
| Max Drawdown (1Y) | -25.59% |
| Max Drawdown (3Y) | -25.59% |
| Sharpe Ratio (1Y) | 0.01 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $224.80 |
| 200-Day Average | $223.45 |
| 52-Week Range | $193.46 to $266.68 |
| RSI (14 Days) | 66.2 |
| Average Volume (20 Days) | 903.72K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.05x current liabilities, and total debt is 0.28x shareholder equity.
| Current Ratio | 2.05x |
|---|---|
| Quick Ratio | 1.44x |
| Debt / Equity | 0.28x |
| Debt / EBITDA | 1.20x |
| Debt / FCF | 2.15x |
| Interest Coverage | 20.75x |
Returns and Efficiency
Return on invested capital is 9.40% over the last 12 months, against a 5-year average of 6.91%.
| Return on Equity (ROE) | 11.43% |
|---|---|
| Return on Assets (ROA) | 7.74% |
| Return on Invested Capital (ROIC) | 9.40% |
| Return on Capital Employed (ROCE) | 12.42% |
| ROE (5Y Average) | 6.35% |
| ROA (5Y Average) | 3.98% |
| ROIC (5Y Average) | 6.91% |
| Asset Turnover | 0.58x |
| Inventory Turnover | 4.72x |
| Receivables Turnover | 6.11x |
| Cash Conversion Cycle | 101 days |
Taxes
Income tax took 26.17% of pretax income over the last 12 months.
| Income Tax (TTM) | $294.10M |
|---|---|
| Effective Tax Rate | 26.17% |
Scores
STE has an Altman Z-Score of 5.87, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.87 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 9 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $6.17B over the last 12 months is up 8.12% from the 12 months before.
| Revenue | $6.17B |
|---|---|
| Revenue Growth (YoY) | +8.12% |
| Gross Profit | $2.75B |
| Operating Income | $1.17B |
| Pretax Income | $1.12B |
| Net Income | $829.70M |
| EBITDA | $1.68B |
| EBIT | $1.18B |
| Reported EPS (TTM) | $10.89 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 67.79% of the $10.71B in total assets.
| Cash and Equivalents | $531.10M |
|---|---|
| Total Debt | $2.01B |
| Net Debt | $1.48B |
| Net Debt Per Share | $15.25 |
| Working Capital | $1.27B |
| Shareholder Equity | $7.26B |
| Book Value Per Share | $74.74 |
| Tangible Book Value | $1.58B |
| Tangible Book Per Share | $16.29 |
| Total Assets | $10.71B |
| Total Liabilities | $3.44B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $352.50M of capital spending, operating cash flow left $937.20M of free cash flow.
| Operating Cash Flow | $1.29B |
|---|---|
| Capital Expenditures | $352.50M |
| Free Cash Flow | $937.20M |
| FCF Per Share | $9.61 |
| Depreciation and Amortization | $494.80M |
| Dividends Paid | $254.40M |
| Share Repurchases | $340.30M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 18.98%, against a 5-year average of 15.89%.
| Gross Margin | 44.56% |
|---|---|
| Operating Margin | 18.98% |
| Pretax Margin | 18.23% |
| Net Margin | 13.46% |
| EBITDA Margin | 27.17% |
| EBIT Margin | 19.15% |
| FCF Margin | 15.20% |
| Gross Margin (5Y Average) | 43.93% |
| Operating Margin (5Y Average) | 15.89% |
| Net Margin (5Y Average) | 8.00% |
Growth
Revenue grew 9.38% a year over 3 years, and EPS 7.40% a year.
| Revenue Growth (3Y CAGR) | +9.38% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.82% |
| EPS Growth (3Y CAGR) | +7.40% |
| EPS Growth (5Y CAGR) | +10.58% |
| FCF Growth (3Y CAGR) | +35.03% |
| FCF Growth (5Y CAGR) | +16.64% |
| Operating Income Growth (3Y CAGR) | +11.68% |
| Book Value Per Share Growth (2Y CAGR) | +7.01% |
| Tangible Book Per Share Growth (2Y CAGR) | +250.14% |
Dividends and Yields
STE pays out 24.62% of earnings as dividends.
| Dividend Per Share (Annual) | $2.76 |
|---|---|
| Dividend Yield | 1.07% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +10.06% |
| Dividend Growth (5Y CAGR) | +9.28% |
| Payout Ratio | 24.62% |
| FCF Payout Ratio | 27.14% |
| Earnings Yield | 4.24% |
| FCF Yield | 3.75% |
| Buyback Yield | 1.36% |
| Shareholder Yield | 2.38% |
Peer Position
Against 9 similar companies, STE has the 4th highest P/E.
P/E RatioPeer median 22.0x
P/S RatioPeer median 3.0x
ROICPeer median 10.80%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.43%
Dividend YieldPeer median 0.20%
| P/E Ratio | 23.6x vs 22.0x median |
|---|---|
| P/S Ratio | 4.1x vs 3.0x median |
| ROIC | 9.40% vs 10.80% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +8.12% vs +7.43% median |
| Dividend Yield | 1.07% vs 0.20% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.31% and EPS growth at 10.67% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.31% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.67% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About STE
What is STE's market cap?
STERIS has a market cap of $25.43B. Its enterprise value, which adds debt and subtracts cash, is $26.91B.
What is STE's P/E ratio?
STERIS has a trailing P/E ratio of 23.6x and a forward P/E of 22.4x.
How many shares of STE are outstanding?
STERIS has 97.11M shares outstanding. The count is down 1.06% from a year earlier.
Does STE pay a dividend?
Yes. STERIS pays $2.76 a share a year, a dividend yield of 1.07%.
How much debt does STE have?
STERIS has $2.01B of total debt and $531.10M of cash and equivalents, a net debt position of $1.48B.
STE pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts